Larvol Delta - Avalon-Pharmaand-BioThera-Solutionsannounce-today-they-have-executed-commercialization-and-license-agreements-for-BAT2406-a-proposed-Dupixent-biosimilar-for-Saudi-Arabia-and-the-rest-of-the-MENA-region

BAT2406 (dupilumab biosimilar) - Bio-Thera Solutions, SteinCares, Avalon Pharma

https://avalon-cms-old.media-bots.com/storage/uploads/2026/08/18/Avalon-pharma-and-Bio-Thera_uid_6a8422953c426.pdf

Aug 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next